OverviewSuggest Edit

BioTelemetry provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing, and centralized core laboratory services for clinical research. The Company operates in three segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. Its services range from the differentiated mobile cardiac telemetry service to the wireless and trans-telephonic event, traditional Holter, extended-wear Holter, Pacemaker and International Normalized Ratio monitoring. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The Technology segment focuses on the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals.

TypePublic
Founded2013
HQMalvern, PA, US
Websitegobio.com
Employee Ratings3.5
Overall CultureD

Latest Updates

Employees (est.) (Dec 2018)1,500(-6%)
Job Openings82
Revenue (FY, 2019)$439.1 M(+10%)
Share Price (Feb 2021)$72
Cybersecurity ratingAMore

Key People/Management at BioTelemetry

Joseph H. Capper

Joseph H. Capper

President and Chief Executive Officer
Kirk Gorman

Kirk Gorman

Chairman
Heather Getz

Heather Getz

EVP, CFO & CAO
Manish Wadhwa

Manish Wadhwa

Chief Medical Officer
Anthony J. Conti

Anthony J. Conti

Board Member
Laura Dietch

Laura Dietch

President and CEO
Show more

BioTelemetry Office Locations

BioTelemetry has offices in Malvern, Eagan, Norfolk, Phoenix and in 8 other locations
Malvern, PA, US (HQ)
1000 Cedar Hollow Rd #102
Eagan, MN, US
1285 Corporate Center Dr #150
Eagan, MN, US
1285 Corporate Center Dr #175
Norfolk, VA, US
5700 Lake Wright Dr #204
Phoenix, AZ, US
2750 S 18th Pl #100
Rochester, NY, US
155 Corporate Woods #180
Show all (13)

BioTelemetry Financials and Metrics

BioTelemetry Revenue

BioTelemetry's revenue was reported to be $439.11 m in FY, 2019
USD

Revenue (Q3, 2020)

114.7m

Gross profit (Q3, 2020)

69.0m

Gross profit margin (Q3, 2020), %

60.2%

Net income (Q3, 2020)

6.7m

EBIT (Q3, 2020)

11.9m

Market capitalization (19-Feb-2021)

2.5b

Closing stock price (19-Feb-2021)

72.0

Cash (30-Sept-2020)

90.2m

EV

2.5b
BioTelemetry's current market capitalization is $2.5 b.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

119.0m111.5m129.5m166.6m178.5m208.3m286.8m399.5m439.1m

Revenue growth, %

(6%)16%29%7%17%

Cost of goods sold

6.2m5.1m50.4m73.1m72.0m78.9m114.4m149.0m164.8m

Gross profit

112.8m106.4m79.1m93.5m106.6m129.5m172.4m250.5m274.3m
Annual
USDY, 2010Y, 2011Y, 2012Y, 2013FY, 2013FY, 2014Y, 2014FY, 2015Y, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

18.7m18.3m18.3m22.2m22.2m20.0m20.0m19.0m19.0m23.1m36.0m80.9m68.6m

Accounts Receivable

11.4m15.2m15.2m25.2m37.8m71.9m

Prepaid Expenses

2.4m2.4m1.5m10.3m5.8m6.5m

Inventories

2.4m2.6m2.6m2.4m2.4m1.5m5.2m5.3m7.3m5.7m
Show all financial metrics

BioTelemetry Operating Metrics

FY, 2015FY, 2016

Patents (Foreign)

81111

Patents (US)

3449

Patents Issued

115160

Trademarks

1722
Show all operating metrics

BioTelemetry Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

BioTelemetry Online and Social Media Presence

Embed Graph

BioTelemetry Company Culture

  • Overall Culture

    D

    61/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    100/100

Learn more on Comparably

BioTelemetry News and Updates

Philips will buy remote patient monitoring company BioTelemetry

Philips said the acquisition "fits perfectly" with its strategy to be a leading provider of in-home care management technology.

SHAREHOLDER ALERT: WeissLaw LLP Investigates BioTelemetry, Inc.

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioTelemetry, Inc. ("BioTelemetry" or the "Company") (NASDAQ: BEAT) in connection with the proposed acquisition of the Company...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of BioTelemetry, Inc. - BEAT

NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating BioTelemetry, Inc. ("BEAT" or the "Company") (BEAT) relating to its...
Show more

BioTelemetry Frequently Asked Questions

  • When was BioTelemetry founded?

    BioTelemetry was founded in 2013.

  • Who are BioTelemetry key executives?

    BioTelemetry's key executives are Joseph H. Capper, Kirk Gorman and Heather Getz.

  • How many employees does BioTelemetry have?

    BioTelemetry has 1,500 employees.

  • What is BioTelemetry revenue?

    Latest BioTelemetry annual revenue is $439.1 m.

  • What is BioTelemetry revenue per employee?

    Latest BioTelemetry revenue per employee is $292.7 k.

  • Who are BioTelemetry competitors?

    Competitors of BioTelemetry include Hologic, Calyx and ZD Medical.

  • Where is BioTelemetry headquarters?

    BioTelemetry headquarters is located at 1000 Cedar Hollow Rd #102, Malvern.

  • Where are BioTelemetry offices?

    BioTelemetry has offices in Malvern, Eagan, Norfolk, Phoenix and in 8 other locations.

  • How many offices does BioTelemetry have?

    BioTelemetry has 13 offices.